Business Description
Curocell Inc
ISIN : KR7372320002
Compare
Compare
Traded in other countries / regions
372320.Korea IPO Date
2023-11-09Description
Curocell Inc is engaged in medical and pharmaceutical research and development. The company is into development of CAR-T treatments that enhance the natural function of immune cells to eliminate cancer cells through genetic manipulation of human immune cells.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.75 | |||||
| Equity-to-Asset | 0.53 | |||||
| Debt-to-Equity | 0.81 | |||||
| Debt-to-EBITDA | -1.55 | |||||
| Piotroski F-Score | 3/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | -19.6 | |||||
| 3-Year EPS without NRI Growth Rate | -27.7 | |||||
| 3-Year FCF Growth Rate | -29.3 | |||||
| 3-Year Book Growth Rate | 116.9 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 54.83 | |||||
| 9-Day RSI | 60.39 | |||||
| 14-Day RSI | 59.64 | |||||
| 6-1 Month Momentum % | -25.94 | |||||
| 12-1 Month Momentum % | -33.02 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.81 | |||||
| Quick Ratio | 0.81 | |||||
| Cash Ratio | 0.78 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -33.7 | |||||
| Shareholder Yield % | -8.71 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -68.24 | |||||
| ROA % | -36.31 | |||||
| ROIC % | -43.77 | |||||
| ROC (Joel Greenblatt) % | -51.64 | |||||
| ROCE % | -40.22 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 9.48 | |||||
| Price-to-Tangible-Book | 9.25 | |||||
| EV-to-EBIT | -14.46 | |||||
| EV-to-EBITDA | -18.05 | |||||
| EV-to-FCF | -15.76 | |||||
| Earnings Yield (Greenblatt) % | -6.91 | |||||
| FCF Yield % | -6.6 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Curocell Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil â‚©) | |||
| EPS (TTM) (â‚©) | -2622 | ||
| Beta | 0 | ||
| Volatility % | 51.92 | ||
| 14-Day RSI | 59.64 | ||
| 14-Day ATR (â‚©) | 2125.170356 | ||
| 20-Day SMA (â‚©) | 27894 | ||
| 12-1 Month Momentum % | -33.02 | ||
| 52-Week Range (â‚©) | 19390 - 43000 | ||
| Shares Outstanding (Mil) | 14.11 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Curocell Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Curocell Inc Stock Events
| Event | Date | Price(â‚©) | ||
|---|---|---|---|---|
| No Event Data | ||||
Curocell Inc Frequently Asked Questions
What is Curocell Inc(XKRX:372320)'s stock price today?
The current price of XKRX:372320 is â‚©30750.00. The 52 week high of XKRX:372320 is â‚©43000.00 and 52 week low is â‚©19390.00.
When is next earnings date of Curocell Inc(XKRX:372320)?
The next earnings date of Curocell Inc(XKRX:372320) is .
Does Curocell Inc(XKRX:372320) pay dividends? If so, how much?
Curocell Inc(XKRX:372320) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers